chr8-89789467-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_003821.6(RIPK2):āc.1270A>Gā(p.Thr424Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,613,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_003821.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPK2 | NM_003821.6 | c.1270A>G | p.Thr424Ala | missense_variant | 10/11 | ENST00000220751.5 | NP_003812.1 | |
RIPK2 | NM_001375360.1 | c.859A>G | p.Thr287Ala | missense_variant | 9/10 | NP_001362289.1 | ||
RIPK2 | XM_011517357.3 | c.757A>G | p.Thr253Ala | missense_variant | 8/9 | XP_011515659.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPK2 | ENST00000220751.5 | c.1270A>G | p.Thr424Ala | missense_variant | 10/11 | 1 | NM_003821.6 | ENSP00000220751 | P1 | |
RIPK2 | ENST00000522965.1 | c.*909A>G | 3_prime_UTR_variant, NMD_transcript_variant | 9/10 | 1 | ENSP00000429271 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000839 AC: 21AN: 250378Hom.: 0 AF XY: 0.0000887 AC XY: 12AN XY: 135328
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461124Hom.: 0 Cov.: 30 AF XY: 0.0000564 AC XY: 41AN XY: 726862
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74468
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at